SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 29.67-2.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Crovelli who wrote (26)8/30/1996 5:03:00 PM
From: John Crovelli   of 455
 
To All:

I received a letter from Michael J. Higgins, VP Finance, dated 8/26/96 in which he passed on the following information:

The PRO 2000 safety studies in Belgium are moving forward with expectation they will be completed late this fall.

The company is also awaiting results from preclinical testing for irritation on a new topical microbicide (intervaginal gel) that is under development. The results of this testing are due end of August, and will determine whether they pursue clinical trials.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext